Ovid Therapeutics Inc. (OVID) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ovid Therapeutics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.958 Good afternoon, everyone. My name is Angela, and I will be your conference operator today. 00:00:04.958 -- 00:00:09.365 At this time, I would like to welcome you to OVID Therapeutics Business and Pipeline 00:00:09.365 -- 00:00:12.810 Update Call. This conference is being recorded. 00:00:12.810 -- 00:00:16.355 All lines have been placed on mute to prevent any background noise. 00:00:16.355 -- 00:00:20.882 After the speaker's prepared remarks, there will be a question and answer session. 00:00:20.882 -- 00:00:24.848 At this time, I would like to turn the call over to Victoria Ford. 00:00:24.848 -- 00:00:26.558 Please proceed. 00:00:26.558 -- 00:00:30.666 Thank you. Good morning, everyone, and thank you for joining us. 00:00:30.666 -- 00:00:35.394 Earlier today, we issued a press release announcing business and pipeline updates and 00:00:35.394 -- 00:00:41.085 financial results for the three months and full year ended December 31st, 2025. 00:00:41.085 -- 00:00:46.615 A copy of the release can be found in the Investor Relations tab on our corporate website, 00:00:46.615 -- 00:00:48.615 AvidRx.com. 00:00:48.850 -- 00:00:53.400 As a reminder, during today's call, we'll be making forward-looking statements. 00:00:53.400 -- 00:00:57.950 Various remarks we make during this call about the company's future expectations, plans, 00:00:57.950 -- 00:01:02.320 and prospects constitute forward-looking statements for the purpose of the safe harbor 00:01:02.320 -- 00:01:07.426 provisions under the Private Securities Litigation Reform Act of 1995. 00:01:07.565 -- 00:01:11.093 Forward-looking statements contained in this call are subject to a number of risks and 00:01:11.093 -- 00:01:15.785 uncertainties, which could cause our actual results to differ ...